Sichuan Goldstone Asia Pharmaceutical Inc. (SHE:300434)

SHE:300434 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Revenue Revenue Growth	1,037	1,038	1,102	1,209	1,243	1,054
Revenue Growth	-3.24%	-5.80%	-8.84%	-2.69%	17.95%	35.53%
Gross Profit Gross Profit Growth	619.65	603.02	629.17	741.21	761.87	593.94
Operating Income Operating Income Growth	164.02	139.29	128.38	240.61	280.8	115.45
Net Income Net Income Growth	161.35	131.62	91.76	126.2	218.79	66.48
Earnings Per Share EPS Growth	0.40	0.33	0.23	0.31	0.54	0.17
EPS Growth	36.38%	43.48%	-25.81%	-42.59%	217.65%	-

Revenue by Segment

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Pharmaceutical Manufacturing Industry Pharmaceutical Manufacturing Industry Growth	866.9	914.52	1,089	1,087	819.01
Machinery manufacturing industry Machinery manufacturing industry Growth	145.15	155.25	86.29	113.82	188.81
Real Estate Leasing and Management Industry Real Estate Leasing and Management Industry Growth	30.02	32.58	34.09	41.88	45.68
Inter-Department Offsetting Inter-Department Offsetting Growth	-3.67	-	-	-	-
Total Total Growth	1,038	1,102	1,209	1,243	1,054

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Investments Cash & Investments Growth	480.97	408.14	446.44	689.79	504.12	289.27
Total Debt Total Debt Growth	107.73	76	77.86	114.83	10.31	0.98
Net Cash (Debt) Net Cash Growth	373.24	332.14	368.59	574.97	493.8	288.29
Net Cash Growth	5.80%	-9.89%	-35.89%	16.44%	71.29%	-39.19%
Net Cash Per Share Net Cash Per Share Growth	0.94	0.83	0.92	1.41	1.22	0.74

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Operating Cash Flow Operating Cash Flow Growth	167.64	207.89	158.15	151.14	323.04	136.4
Capital Expenditures CapEx Growth	-89.71	-99.57	-72.92	-66.1	-54.15	-85.36
Free Cash Flow Free Cash Flow Growth	77.93	108.32	85.23	85.04	268.89	51.03
Free Cash Flow Growth	-74.00%	27.10%	0.22%	-68.37%	426.92%	-47.88%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Gross Margin	59.74%	58.07%	57.07%	61.30%	61.31%	56.38%
Operating Margin	15.81%	13.41%	11.65%	19.90%	22.60%	10.96%
Pretax Margin	18.16%	14.71%	11.13%	14.64%	23.38%	8.88%
Profit Margin	15.55%	12.68%	8.32%	10.44%	17.61%	6.31%
FCF Margin	7.51%	10.43%	7.73%	7.03%	21.64%	4.84%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Sep 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Dividend Per Share Dividend Per Share Growth	0.082	0.082	0.069	0.110
Dividend Per Share Growth	18.84%	18.84%	-37.27%	-
Dividend Yield	0.73%	0.80%	0.85%	1.03%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
PE Ratio	25.00	31.38	36.12	35.21	24.99	65.63
P/FCF Ratio	52.12	38.13	38.89	52.25	20.33	85.50
PS Ratio	3.92	3.98	3.01	3.68	4.40	4.14

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 14, 2026

Data Sources Report a data error